RAF265
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for RAF265, covering 2020-12-19 to 2020-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma [Phase 1, Phase 2]